Target
Atrial natriuretic peptide receptor 1
Ligand
BDBM50262472
Substrate
n/a
Meas. Tech.
ChEBML_1696823
EC50
220±n/a nM
Citation
 Iwaki, TNakamura, YTanaka, TOgawa, YIwamoto, OOkamura, YKawase, YFuruya, MOyama, YNagayama, T Discovery and SAR of a novel series of Natriuretic Peptide Receptor-A (NPR-A) agonists. Bioorg Med Chem Lett 27:4904-4907 (2017) [PubMed]  Article 
Target
Name:
Atrial natriuretic peptide receptor 1
Synonyms:
ANP-A | ANPRA | ANPRA_HUMAN | Atrial natriuretic peptide A-type receptor | Atrial natriuretic peptide receptor | Atrial natriuretic peptide receptor A | GC-A | Guanylate cyclase | NPR-A | NPR1
Type:
PROTEIN
Mol. Mass.:
118919.35
Organism:
Homo sapiens (Human)
Description:
ChEMBL_700223
Residue:
1061
Sequence:
MPGPRRPAGSRLRLLLLLLLPPLLLLLRGSHAGNLTVAVVLPLANTSYPWSWARVGPAVELALAQVKARPDLLPGWTVRTVLGSSENALGVCSDTAAPLAAVDLKWEHNPAVFLGPGCVYAAAPVGRFTAHWRVPLLTAGAPALGFGVKDEYALTTRAGPSYAKLGDFVAALHRRLGWERQALMLYAYRPGDEEHCFFLVEGLFMRVRDRLNITVDHLEFAEDDLSHYTRLLRTMPRKGRVIYICSSPDAFRTLMLLALEAGLCGEDYVFFHLDIFGQSLQGGQGPAPRRPWERGDGQDVSARQAFQAAKIITYKDPDNPEYLEFLKQLKHLAYEQFNFTMEDGLVNTIPASFHDGLLLYIQAVTETLAHGGTVTDGENITQRMWNRSFQGVTGYLKIDSSGDRETDFSLWDMDPENGAFRVVLNYNGTSQELVAVSGRKLNWPLGYPPPDIPKCGFDNEDPACNQDHLSTLEVLALVGSLSLLGILIVSFFIYRKMQLEKELASELWRVRWEDVEPSSLERHLRSAGSRLTLSGRGSNYGSLLTTEGQFQVFAKTAYYKGNLVAVKRVNRKRIELTRKVLFELKHMRDVQNEHLTRFVGACTDPPNICILTEYCPRGSLQDILENESITLDWMFRYSLTNDIVKGMLFLHNGAICSHGNLKSSNCVVDGRFVLKITDYGLESFRDLDPEQGHTVYAKKLWTAPELLRMASPPVRGSQAGDVYSFGIILQEIALRSGVFHVEGLDLSPKEIIERVTRGEQPPFRPSLALQSHLEELGLLMQRCWAEDPQERPPFQQIRLTLRKFNRENSSNILDNLLSRMEQYANNLEELVEERTQAYLEEKRKAEALLYQILPHSVAEQLKRGETVQAEAFDSVTIYFSDIVGFTALSAESTPMQVVTLLNDLYTCFDAVIDNFDVYKVETIGDAYMVVSGLPVRNGRLHACEVARMALALLDAVRSFRIRHRPQEQLRLRIGIHTGPVCAGVVGLKMPRYCLFGDTVNTASRMESNGEALKIHLSSETKAVLEEFGGFELELRGDVEMKGKGKVRTYWLLGERGSSTRG
  
Inhibitor
Name:
BDBM50262472
Synonyms:
CHEMBL4077093
Type:
Small organic molecule
Emp. Form.:
C30H39FN6O
Mol. Mass.:
518.6687
SMILES:
CC(C)Nc1nc(N[C@H]2CC[C@@H](CC2)NC(=O)C2CCCN(C)C2)c2cc(ccc2n1)-c1ccccc1F |r,wU:11.14,wD:8.7,(40.95,-3.29,;39.62,-4.07,;39.63,-5.61,;38.28,-3.3,;36.95,-4.08,;36.96,-5.63,;35.62,-6.4,;35.62,-7.94,;36.95,-8.71,;36.95,-10.24,;38.27,-11.01,;39.61,-10.25,;39.62,-8.71,;38.28,-7.93,;40.94,-11.03,;42.28,-10.26,;42.28,-8.72,;43.61,-11.04,;44.94,-10.27,;46.27,-11.05,;46.26,-12.6,;44.92,-13.35,;44.91,-14.89,;43.6,-12.58,;34.29,-5.63,;32.96,-6.39,;31.63,-5.63,;31.63,-4.08,;32.96,-3.32,;34.29,-4.09,;35.62,-3.31,;30.3,-6.4,;30.31,-7.93,;28.98,-8.71,;27.64,-7.94,;27.63,-6.4,;28.97,-5.63,;28.96,-4.09,)|
Structure:
Search PDB for entries with ligand similarity: